Life Sciences Tools & Services Companies By Operating Cash Flow

Cash Flow From Operations
Cash Flow From OperationsEfficiencyMarket RiskExp Return
1TMO Thermo Fisher Scientific
8.41 B
(0.17)
 1.24 
(0.21)
2IQV IQVIA Holdings
2.15 B
(0.17)
 1.86 
(0.32)
3A Agilent Technologies
1.75 B
 0.00 
 1.63 
 0.00 
4ICLR ICON PLC
1.16 B
(0.16)
 3.45 
(0.56)
5MTD Mettler Toledo International
965.87 M
(0.08)
 1.95 
(0.16)
6AVTR Avantor
870 M
(0.18)
 1.47 
(0.27)
7CRL Charles River Laboratories
683.9 M
 0.03 
 2.58 
 0.09 
8WAT Waters
602.81 M
 0.08 
 2.95 
 0.24 
9ILMN Illumina
478 M
 0.08 
 2.30 
 0.19 
10QGEN Qiagen NV
459.45 M
(0.02)
 1.26 
(0.02)
11MEDP Medpace Holdings
433.37 M
 0.00 
 2.94 
 0.00 
12BIO Bio Rad Laboratories
374.94 M
 0.02 
 2.33 
 0.06 
13BRKR Bruker
350.1 M
(0.06)
 2.68 
(0.16)
14TECH Bio Techne Corp
298.98 M
 0.05 
 2.35 
 0.11 
15FTRE Fortrea Holdings
167.4 M
 0.01 
 5.05 
 0.03 
16MRVI Maravai Lifesciences Holdings
126.22 M
(0.07)
 6.24 
(0.46)
17RGEN Repligen
113.92 M
 0.05 
 3.10 
 0.14 
18RVTY Revvity
91.27 M
(0.02)
 1.64 
(0.03)
19AZTA Azenta Inc
50.29 M
(0.01)
 2.60 
(0.02)
20MLAB Mesa Laboratories
44.13 M
(0.01)
 3.49 
(0.04)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings. Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.